311 related articles for article (PubMed ID: 36498923)
1. Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation.
Paris F; Pizzuti V; Marrazzo P; Pession A; Alviano F; Bonsi L
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498923
[TBL] [Abstract][Full Text] [Related]
2. Wharton's Jelly stem cells: future clinical applications.
Taghizadeh RR; Cetrulo KJ; Cetrulo CL
Placenta; 2011 Oct; 32 Suppl 4():S311-5. PubMed ID: 21733573
[TBL] [Abstract][Full Text] [Related]
3. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.
Anzalone R; Lo Iacono M; Loria T; Di Stefano A; Giannuzzi P; Farina F; La Rocca G
Stem Cell Rev Rep; 2011 Jun; 7(2):342-63. PubMed ID: 20972649
[TBL] [Abstract][Full Text] [Related]
4. Regenerative potential of Wharton's jelly-derived mesenchymal stem cells: A new horizon of stem cell therapy.
Abbaszadeh H; Ghorbani F; Derakhshani M; Movassaghpour AA; Yousefi M; Talebi M; Shamsasenjan K
J Cell Physiol; 2020 Dec; 235(12):9230-9240. PubMed ID: 32557631
[TBL] [Abstract][Full Text] [Related]
5. Pericytes in the Umbilical Cord.
Gauthier-Fisher A; Szaraz P; Librach CL
Adv Exp Med Biol; 2019; 1122():211-233. PubMed ID: 30937871
[TBL] [Abstract][Full Text] [Related]
6. Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation.
Pochon C; Notarantonio AB; Laroye C; Reppel L; Bensoussan D; Bertrand A; Rubio MT; D'Aveni M
J Cell Mol Med; 2022 Mar; 26(5):1339-1350. PubMed ID: 35088933
[TBL] [Abstract][Full Text] [Related]
7. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
Bhonde RR; Sheshadri P; Sharma S; Kumar A
Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
[TBL] [Abstract][Full Text] [Related]
8. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
[TBL] [Abstract][Full Text] [Related]
9. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
[TBL] [Abstract][Full Text] [Related]
11. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Fe
Li X; Wei Z; Wu L; Lv H; Zhang Y; Li J; Yao H; Zhang H; Yang B; Xu X; Jiang J
Biomater Sci; 2020 Oct; 8(19):5362-5375. PubMed ID: 32869785
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells and Psoriasis: Systematic Review.
Diotallevi F; Di Vincenzo M; Martina E; Radi G; Lariccia V; Offidani A; Orciani M; Campanati A
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499401
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.
Joerger-Messerli MS; Marx C; Oppliger B; Mueller M; Surbek DV; Schoeberlein A
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():30-44. PubMed ID: 26482184
[TBL] [Abstract][Full Text] [Related]
15. Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus.
Hu J; Yu X; Wang Z; Wang F; Wang L; Gao H; Chen Y; Zhao W; Jia Z; Yan S; Wang Y
Endocr J; 2013; 60(3):347-57. PubMed ID: 23154532
[TBL] [Abstract][Full Text] [Related]
16. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.
Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A
Front Immunol; 2021; 12():732549. PubMed ID: 34650558
[TBL] [Abstract][Full Text] [Related]
17. The microenvironment of silk/gelatin nanofibrous scaffold improves proliferation and differentiation of Wharton's jelly-derived mesenchymal cells into islet-like cells.
Taherpour A; Hosseini-Khah Z; Zargari M; Ehsan Enderami S
Gene; 2022 Jul; 833():146586. PubMed ID: 35597530
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic endocrine-like cells differentiated from human umbilical cords Wharton's jelly mesenchymal stem cells using small molecules.
Belame Shivakumar S; Bharti D; Baregundi Subbarao R; Park JM; Son YB; Ullah I; Choe YH; Lee HJ; Park BW; Lee SL; Rho GJ
J Cell Physiol; 2019 Apr; 234(4):3933-3947. PubMed ID: 30343506
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.
Liu S; Hou KD; Yuan M; Peng J; Zhang L; Sui X; Zhao B; Xu W; Wang A; Lu S; Guo Q
J Biosci Bioeng; 2014 Feb; 117(2):229-235. PubMed ID: 23899897
[TBL] [Abstract][Full Text] [Related]
20. Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion.
Witkowska-Zimny M; Wrobel E
Cell Mol Biol Lett; 2011 Sep; 16(3):493-514. PubMed ID: 21786036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
